(Q60678860)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7544987%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Interleukin-6 and acute-phase proteins in head and neck cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7544987%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

0 references

0 references

1 reference

1 reference

head and neck carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7544987%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Betti Giusti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7544987%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

O Gallo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7544987%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

M Attanasio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7544987%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

F Martini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7544987%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

T Brunelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7544987%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

E Gallina

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7544987%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7544987%20AND%20SRC:MED&resulttype=core&format=json

European Archives of Oto-Rhino-Laryngology

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7544987%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

252

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7544987%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7544987%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

159-162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7544987%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00178104

20 October 2019

exact match

0 references

cites work

Antitumor activity of recombinant interleukin 6 in mice

1 reference

12 December 2020

Serum glycoproteins in cancer patients: first report of correlations with in vitro and in vivo parameters of cellular immunity

1 reference

12 December 2020

B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes

1 reference

12 December 2020

Serum levels of IL-1, IL-6 and tumour necrosis factors in patients undergoing coronary artery bypass grafts or cholecystectomy

1 reference

12 December 2020

Characterization of a novel cell line from pleomorphic adenoma of the parotid gland with myoepithelial phenotype and producing interleukin-6 as an autocrine growth factor

1 reference

12 December 2020

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

1 reference

12 December 2020

Acute phase reactant proteins--an aid to monitoring surgical treatment of laryngeal carcinoma

1 reference

12 December 2020

Immunosuppressive properties of electrophoretically "slow" and "fast" form alpha 2-macroglobulin. Effects on cell-mediated cytotoxicity and (allo-) antigen-induced T cell proliferation

1 reference

12 December 2020

Preoperative and postoperative cytokines in patients with cancer

1 reference

12 December 2020

Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma

1 reference

12 December 2020

Adoptive immunotherapy with high-dose interleukin-2: kinetics of circulating progenitors correlate with interleukin-6, granulocyte colony-stimulating factor level

1 reference

12 December 2020

IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans

1 reference

12 December 2020

Serum glycoproteins in head and neck squamous carcinoma: correlations with tumor extent, clinical tumor stage, and T-cell levels during chemotherapy

1 reference

12 December 2020

Interleukin-6 serum level and monocyte production in head and neck cancer

1 reference

12 December 2020

[Rapid physiological coagulation method in determination of fibrinogen]

1 reference

12 December 2020

The biology of interleukin-6

1 reference

12 December 2020

Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells

1 reference

12 December 2020

Induction of rat acute-phase proteins by interleukin 6 in vivo

1 reference

12 December 2020

Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer

1 reference

12 December 2020

Interferon-beta 2/interleukin 6 is a co-stimulant for human T lymphocytes

1 reference

12 December 2020

Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer

1 reference

12 December 2020

Enhanced production of IL-6 in tumor-bearing mice and determination of cells responsible for its augmented production

1 reference

12 December 2020

Interleukin-6 and the acute phase response

1 reference

12 December 2020

α1-Antitrypsin is an effector of immunological stasis

1 reference

12 December 2020

IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines

1 reference

12 December 2020

IFN-beta 2/IL-6 augments the activity of human natural killer cells

1 reference

12 December 2020

Modulation of the immune response by plasma protease inhibitors. I. Alpha 2-macroglobulin and alpha 1-antitrypsin inhibit natural killing and antibody-dependent cell-mediated cytotoxicity

1 reference

12 December 2020

Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas

1 reference

12 December 2020

Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00178104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7544987%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference